10-Q Filing

TYME TECHNOLOGIES, INC. CIK: 1537917 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001564590-21-042868`
Period End Date	20210630
Filing Date	20210810
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	tyme-10q_20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 32 Cash Flow Statement 45 Stockholders Equity 20

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$107.52M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$36.46M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$36.16M	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$613.16K	USD	Point-in-time
Prepaid clinical costs	`PrepaidClinicalCostsCurrent`	$987.47K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.45M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.15M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$109.66M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$74.69M	USD	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Prepaid clinical costs, net of current portion	`PrepaidClinicalCostsNoncurrent`	$530.99K	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$66.56K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$75.47K	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$28.34M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$110.26M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$103.10M	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	172.20M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	172.21M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	172.21M	shares	Point-in-time
Accounts payable and other current liabilities (including $101,000 and $87,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.56M	USD	Point-in-time
Accounts payable and other current liabilities (including $101,000 and $87,000 of related party accounts payable, respectively)	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.84M	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$661.76K	USD	Point-in-time
Severance payable	`SeverancePayableCurrent`	$726.03K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$370.60K	USD	Point-in-time
Accrued bonuses	`EmployeeRelatedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$34.66K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityCurrent`	$37.73K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.63M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.64M	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$746.97K	USD	Point-in-time
Severance payable	`SeverancePayableNoncurrent`	$850.71K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$30.41K	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$41.26K	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$1.21M	USD	Point-in-time
Warrant liability	`WarrantLiabilityNoncurrent`	$1.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.47M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.62M	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (see Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,206,894 issued and outstanding at June 30, 2021, 300,000,000 authorized, 172,200,644 issued and outstanding at March 31, 2021	`CommonStockValue`	$17.22K	USD	Point-in-time
Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,206,894 issued and outstanding at June 30, 2021, 300,000,000 authorized, 172,200,644 issued and outstanding at March 31, 2021	`CommonStockValue`	$17.22K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$239.22M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$238.57M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-33.84K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-142.72M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-136.79M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$96.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$19.03M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$101.80M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$15.83M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$103.10M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$110.26M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$115.00K	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	-	USD	1 Quarter
Related party legal expenses	`RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty`	$203.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.18M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.72M	USD	1 Quarter
General and administrative (including $115,000 and $203,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$3.06M	USD	1 Quarter
General and administrative (including $115,000 and $203,000 of related party legal expenses, respectively)	`GeneralAndAdministrativeExpense`	$2.47M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$7.77M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$6.65M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.77M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-6.65M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.26M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-725.14K	USD	1 Quarter
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$10.50K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$19.52K	USD	1 Quarter
Interest expense	`InterestExpense`	$29.38K	USD	1 Quarter
Interest expense	`InterestExpense`	$21.26K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$723.41K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-1.05M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted loss per common share	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	124.58M	shares	1 Quarter
Basic and diluted weighted average shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	172.21M	shares	1 Quarter
Net loss	`NetIncomeLoss`	$-5.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-33.84K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.83M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.96M	USD	1 Quarter

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-5.93M	USD	1 Quarter
Net loss	`ProfitLoss`	$-8.83M	USD	1 Quarter
Depreciation	`Depreciation`	$1.29K	USD	1 Quarter
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$643.66K	USD	1 Quarter
Amortization of employees, directors and consultants stock options	`ShareBasedCompensation`	$1.07M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$3.26M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-725.14K	USD	1 Quarter
Gain on warrant exchange	`GainLossOnWarrantExchange`	$2.23M	USD	1 Quarter
Net amortization of premiums and discounts on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-227.31K	USD	1 Quarter
Change in unrealized gain (loss)	`UnrealizedGainLossOnInvestments`	$7.00	USD	1 Quarter
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$-905.30K	USD	1 Quarter
Prepaid clinical costs	`IncreaseDecreaseInPrepaidClinicalCosts`	$188.56K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-248.63K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-186.63K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-69.51K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-8.91K	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.64M	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-280.96K	USD	1 Quarter
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-91.90K	USD	1 Quarter
Severance payable	`IncreaseDecreaseInSeverancePayable`	$-168.00K	USD	1 Quarter
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-670.11K	USD	1 Quarter
Accrued bonuses	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.33M	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-7.78K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-14.61K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.81M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.39M	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$65.25M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-65.25M	USD	1 Quarter
Insurance note payments	`InsuranceNotePayments`	$170.67K	USD	1 Quarter
Proceeds from registered offerings, net of issuance costs	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$1.17M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$6.19K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.00M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$6.19K	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-71.06M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-5.39M	USD	1 Quarter
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$107.52M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.31M	USD	Point-in-time
Cash and cash equivalents beginning	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$36.46M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$26.70M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$107.52M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$21.31M	USD	Point-in-time
Cash and cash equivalents ending	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$36.46M	USD	Point-in-time
Interest	`InterestPaidNet`	$29.38K	USD	1 Quarter
Interest	`InterestPaidNet`	$21.26K	USD	1 Quarter

Stockholders Equity 20 line items

Line Item	Tag	Value	Unit	Period
Balance, at beginning	`StockholdersEquity`	$96.48M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$101.80M	USD	Point-in-time
Balance, at beginning	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Balance, at beginning (in shares)	`CommonStockSharesOutstanding`	172.21M	shares	Point-in-time
Proceeds from the exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.19K	USD	1 Quarter
Proceeds from the exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	6,250.00	shares	1 Quarter
Warrant to share exchange	`StockIssuedDuringPeriodValueWarrantToShareExchange`	$3.39M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.07M	USD	1 Quarter
Stock based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$643.66K	USD	1 Quarter
Unrealized loss on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-33.84K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.83M	USD	1 Quarter
Balance, at end	`StockholdersEquity`	$96.48M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$19.03M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$101.80M	USD	Point-in-time
Balance, at end	`StockholdersEquity`	$15.83M	USD	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	172.20M	shares	Point-in-time
Balance, at end (in shares)	`CommonStockSharesOutstanding`	172.21M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.